Recent meaningful negative changes in fundamentals have impacted Avanos Medical Inc (NYSE: AVNS): the consensus estimate for December, 2025 decreased significantly, significant quarterly earnings deceleration occurred, and the consensus estimate for December, 2026 decreased significantly.
Avanos Medical Inc (NYSE: AVNS) suffers from meaningful negative changes in investment behavior: its shorter term price trend turned down.
In light of these highly negative signals we are reviewing our current Overall Rating of C. We would view the shares with caution pending completion of this review in the next several days.
Current PriceTarget Research Rating
Avanos Medical has a current Value Trend Rating of C (Low Neutral). The Value Trend Rating reflects very contradictory signals from PTR’s two proprietary measures of a stock’s attractiveness. Avanos Medical has a slightly positive Appreciation Score of 68 but a very low Power Rating of 14, leading to the Low Neutral Value Trend Rating.
Recent Price Action
On 9/19/25, Avanos Medical Inc (NYSE: AVNS) stock declined by -3.0%, closing at $11.91. Moreover, this decline was accompanied by unusually high trading volume at 198% of normal. The stock has declined -4.0% during the last week and has been extremely weak relative to the market over the last nine months.
Be the first to comment